A peptide brand built around verification, consistency and professional partnership.
A medical practice’s product portfolio should reflect the same level of care and professionalism as the practice itself. Unvari was created to deliver a more considered peptide brand experience for qualified healthcare organizations.
Our products are manufactured in the United States by Alpha BioMed Labs, independently tested by third-party laboratories and supported by production-lot documentation.
Unvari is the brand owner. Clinic Protocols supports distribution and professional practice relationships. Patient-specific compounded preparations are dispensed by participating licensed compounding pharmacies after receipt of an appropriate practitioner order.
Start a ConversationConfidence comes from documentation—not assumptions.
Each released Unvari production lot is supported by third-party analytical testing and a corresponding Certificate of Analysis.
U.S. Manufacturing
Unvari products are manufactured in the United States by Alpha BioMed Labs using documented production procedures and quality-control processes.
Third-Party Testing
Each released production lot is supported by independent analytical testing performed by a third-party laboratory.
Batch-Specific COAs
Certificates of Analysis are maintained by production lot and made available to qualified professional partners.
Professional Support
Clinic Protocols supports qualified practices with partnership information, documentation and responsive account communication.
A focused portfolio for qualified medical practices.
Formulation availability, prescription requirements, pharmacy coverage and supporting documentation are confirmed directly through the professional partnership process.
2X Blend
CJC-1295 No DAC / Ipamorelin
BPC-157
10 mg vial
GHK-Cu
50 mg vial
Glow
GHK-Cu / BPC-157 / TB500
NAD+
1000 mg vial
Tesamorelin
10 mg vial
Thymosin Alpha 1
TA1 · 10 mg vial
Wolverine Blend
BPC-157 / TB500
Formulation names, ingredients and vial formats are presented for qualified professional business inquiries only. Products are not sold directly through this website. Patient-specific prescriptions and practitioner authorization are required. Availability is subject to patient eligibility, practitioner licensure, pharmacy coverage, formulation availability and applicable federal and state requirements. This information does not constitute medical advice, prescribing guidance, a treatment recommendation or a representation of FDA approval.
From qualified practice to patient-specific fulfillment.
Unvari does not sell prescription products directly through this website. The website begins a business relationship with qualified medical practices.
Qualify Your Practice
An authorized representative submits a partnership inquiry and provides information about the medical practice and practitioner team.
Practitioner Places Order
An appropriately licensed practitioner evaluates the patient and places an order supported by a valid patient-specific prescription.
Pharmacy Review
The participating licensed compounding pharmacy independently reviews the prescription, patient information and applicable dispensing requirements.
Authorized Fulfillment
Following pharmacy authorization, the patient-specific order is shipped by the dispensing pharmacy or through an authorized logistics partner operating under the applicable fulfillment arrangement.
Unvari’s network supports nationwide partnership and fulfillment capabilities. Actual availability in a particular state depends on practitioner licensure, participating pharmacy coverage, patient eligibility, formulation availability and applicable state and federal requirements.
Bring a higher standard to your peptide portfolio.
Complete the partnership form and a member of the Unvari or Clinic Protocols team will contact you to learn more about your practice, professional requirements and partnership interests.
Tell us about your practice.
Required information helps our team review and respond to your business inquiry.
Corporate roles may vary by product, prescription, state, dispensing pharmacy and fulfillment arrangement. The dispensing pharmacy identified in the applicable prescription and patient materials remains responsible for its independent pharmacy review and dispensing activities.